...
首页> 外文期刊>The Pediatric infectious disease journal >Prospective characterization of norovirus compared with rotavirus acute diarrhea episodes in chilean children.
【24h】

Prospective characterization of norovirus compared with rotavirus acute diarrhea episodes in chilean children.

机译:与智利儿童轮状病毒急性腹泻发作相比,诺如病毒的前瞻性特征。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Rotavirus and more recently noroviruses are recognized as main causes of moderate to severe acute diarrhea episodes (ADE) in children < or =5 years of age. Comparing epidemiologic and clinical features of norovirus to rotavirus ADE will aid in the decision-making process required to develop norovirus vaccines. METHODS: Surveillance for ADE occurring in children < or =5 years of age was implemented in the emergency department (ED) and ward of a large hospital in Santiago and Valparaiso, and in 4 outpatient clinics in Santiago. A stool sample was obtained within 48 hours of consultation for rotavirus detection by enzyme-linked immunosorbent assay and noroviruses by enzyme-linked immunosorbent assay or reverse transcription polymerase chain reaction. For ED and hospital rotavirus and norovirus ADE parents were instructed to monitor clinical findings associated with severity until the end of the episode. The 20-point Vesikari score was used to determine disease severity. RESULTS: Between July 2006 and October 2008 rotavirus and noroviruses were detected in 331 (26%) and 224 (18%) of 1913 ADE evaluated. The proportion of rotavirus-positive samples in hospital ward, ED, and outpatient clinic was 40%, 26% to 30%, and 13% compared with 18%, 17% to 19%, and 14% for noroviruses. Mean age and 25%-75% interquartile interval of children with rotavirus and norovirus ADE were remarkably similar, 15.6 months (9-20), and 15.5 months (9-19), respectively. Rotavirus cases displayed an autumn-winter peak followed 2 to 3 months later by the norovirus peak. The mean (interquartile) for the Vesikari score was 12.9 (11-15) and 11.9 (9-14.5) for rotavirus (N = 331) and norovirus (N = 224) ADE, respectively, P = 0.003. Compared with norovirus, rotavirus ADE were more common in the 11 to 16 severity score interval (P = 0.006), had a higher maximum stool output in a given day (P = 0.01) and more frequent fever (P < 0.0001). Duration of diarrhea, presence, duration and intensity of vomiting, and intensity of fever did not differ between viruses. Mixed rotavirus and norovirus infections were uncommon (<1%) and not clinically more severe. Clinical severity of ADE in young infants was similar for rotavirus and lower (P = 0.03) for noroviruses compared with older children. CONCLUSION: Noroviruses are a significant cause of moderate to severe endemic ADE in Chilean children. Although significantly less severe than rotavirus as a group, most norovirus episodes were moderate to severe clinically. An effective norovirus vaccine would be of significant additional benefit to the current rotavirus vaccine in decreasing disease burden associated with ADE.
机译:背景:轮状病毒和最近的诺如病毒被认为是5岁以下儿童中重度急性腹泻的主要病因。将诺如病毒与轮状病毒ADE的流行病学和临床特征进行比较,将有助于开发诺如病毒疫苗所需的决策过程。方法:在圣地亚哥和瓦尔帕莱索的一家大型医院的急诊室和病房以及圣地亚哥的4家门诊进行了5岁以下儿童中ADE的监测。在咨询的48小时内获得粪便样品,用于通过酶联免疫吸附测定法检测轮状病毒,并通过酶联免疫吸附测定法或逆转录聚合酶链反应检测诺如病毒。对于ED,医院轮状病毒和诺如病毒ADE要求父母监测与严重程度相关的临床发现,直到发作结束。 Vesikari评分为20分,用于确定疾病的严重程度。结果:在2006年7月至2008年10月之间,在评估的1913年ADE中有331例(26%)和224例(18%)检测到轮状病毒和诺如病毒。轮状病毒阳性样本在医院病房,急诊室和门诊中的比例分别为40%,26%至30%和13%,而诺如病毒的比例为18%,17%至19%和14%。轮状病毒和诺如病毒ADE患儿的平均年龄和25%-75%的四分位数间隔分别非常相似,分别为15.6个月(9-20)和15.5个月(9-19)。轮状病毒病例显示出秋冬高峰,随后2至3个月出现诺如病毒高峰。轮状病毒(N = 331)和诺如病毒(N = 224)ADE的Vesikari评分的平均值(四分位数)分别为12.9(11-15)和11.9(9-14.5),P = 0.003。与诺如病毒相比,轮状病毒ADE在11至16个严重度评分区间中更为常见(P = 0.006),在一天中的最大粪便输出量更高(P = 0.01),发烧频率更高(P <0.0001)。病毒的腹泻持续时间,存在的时间,呕吐的持续时间和强度以及发烧强度没有差异。轮状病毒和诺如病毒混合感染并不常见(<1%),临床上并不严重。与年龄较大的儿童相比,轮状病毒婴儿的ADE的临床严重程度相似,而诺如病毒较低(P = 0.03)。结论:诺如病毒是智利儿童中度至重度地方性ADE的重要原因。尽管整体上不如轮状病毒严重,但大多数诺如病毒发作在临床上为中度至重度。有效的诺如病毒疫苗在减轻与ADE相关的疾病负担方面,将对当前的轮状病毒疫苗产生重大的额外好处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号